Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Cardiology

Journal Scan / Research · June 05, 2014

Efficacy and Safety of Nebivolol and Valsartan in Hypertension

The Lancet

 

Additional Info

Disclosure statements are available on the authors' profiles:

The Lancet
Efficacy and Safety of Nebivolol and Valsartan as Fixed-Dose Combination in Hypertension: A Randomised, Multicentre Study
Lancet 2014 May 31;383(9932)1889-1898, TD Giles, MA Weber, J Basile, AH Gradman, DB Bharucha, W Chen, M Pattathil

Further Reading